166 related articles for article (PubMed ID: 12495937)
1. Selective inhibition of large-to-small surfactant aggregate conversion by serine protease inhibitors of the bis-benzamidine type.
Ruppert C; Pucker C; Markart P; Schmidt R; Grimminger F; Seeger W; Stürzebecher J; Günther A
Am J Respir Cell Mol Biol; 2003 Jan; 28(1):95-102. PubMed ID: 12495937
[TBL] [Abstract][Full Text] [Related]
2. Surfactant subtype conversion is related to loss of surfactant apoprotein B and surface activity in large surfactant aggregates. Experimental and clinical studies.
Günther A; Schmidt R; Feustel A; Meier U; Pucker C; Ermert M; Seeger W
Am J Respir Crit Care Med; 1999 Jan; 159(1):244-51. PubMed ID: 9872845
[TBL] [Abstract][Full Text] [Related]
3. Impact of surface tension on the conversion rate of large to small surfactant aggregates.
Ruppert C; Pucker C; Markart P; Seibold K; Bagheri A; Grimminger F; Seeger W; Günther A
Biophys Chem; 2003 May; 104(1):229-38. PubMed ID: 12834841
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of bovine beta-trypsin, human alpha-thrombin and porcine pancreatic beta-kallikrein-B by benzamidine and its bis-, tris- and tetra-derivatives: thermodynamic and molecular modeling study.
Menegatti E; Ferroni R; Nastruzzi C; Bortolotti F; Scalia S; Amiconi G; Bolognesi M; Coletta M; Onesti S; Fruttero R
Farmaco; 1991 Nov; 46(11):1297-310. PubMed ID: 1811616
[TBL] [Abstract][Full Text] [Related]
5. Inhalation of alpha(1)-protease inhibitor in cystic fibrosis does not affect surfactant convertase and surface activity.
Griese M; von Bredow C; Birrer P; Schams A
Pulm Pharmacol Ther; 2001; 14(6):461-7. PubMed ID: 11782126
[TBL] [Abstract][Full Text] [Related]
6. Liver carboxylesterase cleaves surfactant protein (SP-) B and promotes surfactant subtype conversion.
Ruppert C; Bagheri A; Markart P; Schmidt R; Seeger W; Günther A
Biochem Biophys Res Commun; 2006 Oct; 348(4):1449-54. PubMed ID: 16919595
[TBL] [Abstract][Full Text] [Related]
7. Active site mapping of trypsin, thrombin and matriptase-2 by sulfamoyl benzamidines.
Dosa S; Stirnberg M; Lülsdorff V; Häußler D; Maurer E; Gütschow M
Bioorg Med Chem; 2012 Nov; 20(21):6489-505. PubMed ID: 23026080
[TBL] [Abstract][Full Text] [Related]
8. Design of benzamidine-type inhibitors of factor Xa.
Gabriel B; Stubbs MT; Bergner A; Hauptmann J; Bode W; Stürzebecher J; Moroder L
J Med Chem; 1998 Oct; 41(22):4240-50. PubMed ID: 9784099
[TBL] [Abstract][Full Text] [Related]
9. Low molecular weight activated protein C inhibitors as a potential treatment for hemophilic disorders.
De Nanteuil G; Gloanec P; Béguin S; Giesen PL; Hemker HC; Mennecier P; Rupin A; Verbeuren TJ
J Med Chem; 2006 Aug; 49(17):5047-50. PubMed ID: 16913694
[TBL] [Abstract][Full Text] [Related]
10. Effects of surfactant subfractions on preterm rabbit lung function.
Yamada T; Ikegami M; Jobe AH
Pediatr Res; 1990 Jun; 27(6):592-8. PubMed ID: 2356104
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human mast cell tryptase by benzamidine derivatives.
Stürzebecher J; Prasa D; Sommerhoff CP
Biol Chem Hoppe Seyler; 1992 Oct; 373(10):1025-30. PubMed ID: 1418674
[TBL] [Abstract][Full Text] [Related]
12. An examination of the different variables affecting surfactant aggregate conversion in vitro.
Veldhuizen RA; Yao LJ; Lewis JF
Exp Lung Res; 1999 Mar; 25(2):127-41. PubMed ID: 10188107
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of benzamidine-type thrombin inhibitors.
Hauptmann J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):89-97. PubMed ID: 6177614
[TBL] [Abstract][Full Text] [Related]
14. A Bisbenzamidine Phosphonate as a Janus-faced Inhibitor for Trypsin-like Serine Proteases.
Häußler D; Scheidt T; Stirnberg M; Steinmetzer T; Gütschow M
ChemMedChem; 2015 Oct; 10(10):1641-6. PubMed ID: 26306030
[TBL] [Abstract][Full Text] [Related]
15. Degradation of surfactant-associated protein B (SP-B) during in vitro conversion of large to small surfactant aggregates.
Veldhuizen RA; Inchley K; Hearn SA; Lewis JF; Possmayer F
Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):141-7. PubMed ID: 8216208
[TBL] [Abstract][Full Text] [Related]
16. Dissociation of surfactant protein B from canine surfactant large aggregates during formation of small surfactant aggregates by in vitro surface area cycling.
Inchley K; Cockshutt A; Veldhuizen R; Possmayer F
Biochim Biophys Acta; 1999 Aug; 1440(1):49-58. PubMed ID: 10477824
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of serine proteinases by benzamidine derivatives.
Walsmann P
Acta Biol Med Ger; 1977; 36(11-12):1931-7. PubMed ID: 616739
[TBL] [Abstract][Full Text] [Related]
18. Effects of Stachybotrys chartarum on surfactant convertase activity in juvenile mice.
Mason CD; Rand TG; Oulton M; MacDonald J; Anthes M
Toxicol Appl Pharmacol; 2001 Apr; 172(1):21-8. PubMed ID: 11264019
[TBL] [Abstract][Full Text] [Related]
19. Surfactant degradation activity in bronchoalveolar lavage fluid from guinea pigs challenged with antigen.
Abo M; Kurashima K; Fujimura M; Myou S; Nakao S; Tashiro K; Kobayashi T
Respirology; 2007 Nov; 12(6):828-33. PubMed ID: 17986110
[TBL] [Abstract][Full Text] [Related]
20. [Synthetic inhibitors of serine proteinases. Part 25: Inhibition of trypsin, plasmin and thrombin by amides of N alpha-substituted amidinophenylalanines and 3-amidinophenyl-3-aminopropionic acids (author's transl)].
Stürzebecher J; Horn H; Markwardt F; Wagner G; Walsmann P
Pharmazie; 1981 Sep; 36(9):639-41. PubMed ID: 6458047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
